Merck Repatriates Diabetes And Thyroids Portfolio In Russia To Continue To Drive Emerging Markets Strategy

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced the repatriation of all responsibility for its diabetes and thyroid brands in Russia back to the company. The move, effective as of January 1, 2015, transfers all activities for these brands from Merck’s marketing partner Takeda Pharmaceutical Company Limited back to Merck in Russia.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC